Suppliers / Novugen Pharma Malaysia Sdn Bhd

Novugen Pharma Malaysia Sdn Bhd

Malaysia Updated 9 July 2026

Novugen Pharma Malaysia Sdn Bhd is an API manufacturer based in Malaysia. It holds 3 active US drug master files across a filed portfolio of 3 molecules.

3
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Albendazole US FDA 1
Fingolimod US FDA 1
Solifenacin Succinate US FDA 1

Also appears on these molecule pages

Albendazole API Fingolimod API Solifenacin API

Questions about Novugen Pharma Malaysia Sdn Bhd

Does Novugen Pharma Malaysia Sdn Bhd hold a US DMF or a CEP?
Novugen Pharma Malaysia Sdn Bhd holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Novugen Pharma Malaysia Sdn Bhd make?
3 molecules are on record against Novugen Pharma Malaysia Sdn Bhd, including Albendazole, Fingolimod and Solifenacin Succinate. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Novugen Pharma Malaysia Sdn Bhd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Zydus Lifesciences shares 2 molecules MSN Laboratories shares 1 molecule Cipla shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Alivus Life Sciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability